WGS Genedx Holdings Corp
Which ETFs hold WGS? Genedx Holdings Corp is held by 2 funds tracked by ETFpeek.
HealthcareDiagnostics & Research
$67.73
-44.4% 1y
$32.2152-week range$170.87
Market cap
$2.2B
3-month
+3.2%
CEO
Ms. Katherine A. Stueland
Revenue · last 4 qtrs (+11.4% YoY)
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Provider
Currently Held By
ARK
ARKG
ARK Genomic Revolution ETF
Weight in fund1.70%
Shares held515,373
Market value$34.9M
View fund →
ARKARKK
ARK Innovation ETF
Weight in fund0.93%
Shares held944,048
Market value$63.9M
View fund →
Not held by the selected provider.
Insider Activity
last 90 daysNo insider activity recorded in the last 90 days.
Trade History
9 trades| Date | Fund | Direction | Shares Changed | % Δ ETF | % Δ Position |
|---|---|---|---|---|---|
| 15 Sep 2026 | ARKK | SELLReduced | -22,584 | +0.03% | 2.36% |
| 14 Sep 2026 | ARKK | SELLReduced | -7,627 | +0.01% | 0.79% |
| 7 Aug 2026 | ARKK | BUYAdded | +19,509 | +0.03% | 1.98% |
| 7 Aug 2026 | ARKG | BUYAdded | +12,685 | +0.09% | 2.54% |
| 6 Aug 2026 | ARKK | BUYAdded | +34,525 | +0.03% | 3.58% |
| 6 Aug 2026 | ARKG | BUYAdded | +22,490 | +0.04% | 4.62% |
| 5 Aug 2026 | ARKK | BUYAdded | +54,621 | +0.06% | 5.79% |
| 5 Aug 2026 | ARKG | BUYAdded | +18,742 | +0.11% | 4.05% |
| 12 Jun 2026 | ARKK | SELLReduced | -86,590 | +0.03% | 6.62% |
| No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal. | |||||